Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 17, 2018 06:00 ET | Source: Athersys, Inc.

Healios Agrees to Make Payment to Extend Exclusive Period for Negotiating an Option for a License to Multistem® Therapy for Indications in China

CLEVELAND, Ohio, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today the extension of HEALIOS K.K.’s (Healios) exclusive period to negotiate an option that would allow...
November 06, 2018 16:05 ET | Source: Athersys, Inc.

Athersys Reports Third Quarter 2018 Results

Management to host conference call at 4:30pm EST today CLEVELAND, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the period ended...
October 09, 2018 16:00 ET | Source: Athersys, Inc.

Athersys to Host Third Quarter Financial Results Call

CLEVELAND, Ohio, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) will release its third quarter 2018 financial results at approximately 4:00 p.m. Eastern Time on Tuesday, November...
September 24, 2018 06:00 ET | Source: Athersys, Inc.

Athersys to Present at 2018 Cell & Gene Meeting on the Mesa

CEO invited to provide corporate overview and speak in two workshops focusing on innovative development initiatives in Japan and advanced manufacturing technologies CLEVELAND, Ohio, Sept. 24, 2018 ...
August 07, 2018 16:05 ET | Source: Athersys, Inc.

Athersys Reports Second Quarter 2018 Results

CLEVELAND, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended June 30, 2018. Highlights of the second quarter of 2018...
August 03, 2018 06:00 ET | Source: Athersys, Inc.

Athersys Makes Important Leadership Hire to Carry Out Its Manufacturing Strategy

CLEVELAND, Aug. 03, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced the addition of an experienced manufacturing executive to oversee manufacturing operations and help plan for and...
July 31, 2018 06:00 ET | Source: Athersys, Inc.

Athersys Announces Enrollment of First Patient in Masters-2 Phase 3 Study of Multistem® Treatment for Ischemic Stroke

Pivotal study has received a Special Protocol Assessment (SPA), Fast Track Designation, and Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) ...
July 10, 2018 16:00 ET | Source: Athersys, Inc.

Athersys to Host Second Quarter Financial Results Call

CLEVELAND, July 10, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) will release its second quarter 2018 financial results at approximately 4:00 PM Eastern Time on Tuesday, August 7th, 2018,...
June 07, 2018 06:00 ET | Source: Athersys, Inc.

Athersys Announces Expansion of Collaboration With Healios

Healios receives rights to develop and commercialize additional indications and Athersys receives $20 million in license fees, plus potential milestones payments and royalties Discussions extended...
June 07, 2018 02:00 ET | Source: Athersys, Inc.

Athersys Announces Expansion of Collaboration With Healios

Healios receives rights to develop and commercialize additional indications and Athersys receives $20 million in license fees, plus potential milestones payments and royalties Discussions extended...